AIP
COGT icon

Ameritas Investment Partners’s Cogent Biosciences COGT Stock Holding History

Ameritas Investment Partners’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$586K Buy
15,134
+3,421
+29% +$120K 0.02% 840
2026
Q1 		$451K Buy
11,713
+429
+4% +$15.8K 0.01% 874
2025
Q4 		$401K Buy
11,284
+445
+4% +$12.5K 0.01% 890
2025
Q3 		$156K Hold
10,839
– – ﹤0.01% 1389
2025
Q2 		$77.8K Buy
10,839
+1,543
+17% +$8.55K ﹤0.01% 1910
2025
Q1 		$55.7K Hold
9,296
– – ﹤0.01% 2048
2024
Q4 		$72.5K Hold
9,296
– – ﹤0.01% 1967
2024
Q3 		$100K Buy
9,296
+1,167
+14% +$11.4K ﹤0.01% 1778
2024
Q2 		$68.5K Hold
8,129
– – ﹤0.01% 1963
2024
Q1 		$54.6K Hold
8,129
– – ﹤0.01% 2096
2023
Q4 		$47.8K Hold
8,129
– – ﹤0.01% 2191
2023
Q3 		$79.3K Buy
8,129
+2,435
+43% +$28.9K ﹤0.01% 1815
2023
Q2 		$67.4K Buy
5,694
+675
+13% +$7.74K ﹤0.01% 1859
2023
Q1 		$54.2K Hold
5,019
– – ﹤0.01% 1932
2022
Q4 		$67K Hold
5,019
– – ﹤0.01% 1862
2022
Q3 		$74K Buy
5,019
+2,106
+72% +$28.9K ﹤0.01% 1706
2022
Q2 		$26K Hold
2,913
– – ﹤0.01% 2409
2022
Q1 		$22K Hold
2,913
– – ﹤0.01% 2513
2021
Q4 		$25K Hold
2,913
– – ﹤0.01% 2532
2021
Q3 		$24K Hold
2,913
– – ﹤0.01% 2596
2021
Q2 		$24K Buy
+2,913
New +$24.6K ﹤0.01% 2643
2019
Q2 		– Sell
-69
Closed -$1K – 3056
2019
Q1 		$1K Hold
69
– – ﹤0.01% 2963
2018
Q4 		$1K Hold
69
– – ﹤0.01% 2979
2018
Q3 		$3K Hold
69
– – ﹤0.01% 2985
2018
Q2 		$4K Buy
+69
New +$3.32K ﹤0.01% 2951

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameritas Investment Partners's COGT Position: Q2 2026 in Review

Ameritas Investment Partners increased its Cogent Biosciences (COGT) stake by 29% in Q2 2026, buying an estimated $120K and bringing the position to 15,134 shares worth $586K. The position accounts for 0.02% of the portfolio, ranked #840.

Ameritas Investment Partners first reported a position in COGT in Q2 2018 and has held it in 25 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Ameritas Investment Partners held 15,134 shares of Cogent Biosciences worth $586K as of Q2 2026.
  • Ameritas Investment Partners bought 3,421 Cogent Biosciences shares in Q2 2026, an estimated $120K.
  • Cogent Biosciences made up 0.02% of Ameritas Investment Partners's portfolio in Q2 2026, its #840 holding.
  • Ameritas Investment Partners first reported a position in Cogent Biosciences in Q2 2018 and has held it in 25 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.